A STUDY OF THE EFFECT OF FIBER CONTENT AND FIBER ORIENTATION ON THE TENSILE STRENGTH OF GLASS FIBER REINFORCED EPOXY COMPOSITE FOR PIPE PRODUCTION: A STATISTICAL APPROACH
Jurnal Mekanikal · 2023
DOI: 10.11113/jm.v45.455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Mekanikal, 2023. Verfasst von Bassey Samuel und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This study was aimed at optimizing the development parameters of a glass fiber reinforced epoxy composite for pipeline application. In this study, the Taguchi experimental design technique was applied to determine the best combination of process parameters (fiber content and orientation) for optimum tensile strength. The optimum tensile strength of 209.65MPa was reported at the fiber content of 50% and Fiber orientation of 45º. Analysis of variance also showed that in optimizing for high tensile strength, the glass fiber content and the fiber orientation are significant factors. The material at optimum tensile properties was applied in the simulation of the behavior of a high-pressured gas pipeline and results proved the reliability of the material in such application.
Zitieren
APA
Samuel, B., Yawas, D. S., & Akpan, I. (2023). A STUDY OF THE EFFECT OF FIBER CONTENT AND FIBER ORIENTATION ON THE TENSILE STRENGTH OF GLASS FIBER REINFORCED EPOXY COMPOSITE FOR PIPE PRODUCTION: A STATISTICAL APPROACH. Jurnal Mekanikal. https://doi.org/10.11113/jm.v45.455
Vancouver
Samuel B, Yawas DS, Akpan I. A STUDY OF THE EFFECT OF FIBER CONTENT AND FIBER ORIENTATION ON THE TENSILE STRENGTH OF GLASS FIBER REINFORCED EPOXY COMPOSITE FOR PIPE PRODUCTION: A STATISTICAL APPROACH. Jurnal Mekanikal. 2023. doi:10.11113/jm.v45.455
BibTeX
@article{Samuel2023,
author = {Samuel, Bassey and Yawas, Danjuma Saleh and Akpan, Imaobong},
title = {A STUDY OF THE EFFECT OF FIBER CONTENT AND FIBER ORIENTATION ON THE TENSILE STRENGTH OF GLASS FIBER REINFORCED EPOXY COMPOSITE FOR PIPE PRODUCTION: A STATISTICAL APPROACH},
journal = {Jurnal Mekanikal},
year = {2023},
doi = {10.11113/jm.v45.455}
}
EUVIMED